Furthermore, CSF1R-expressing cells protect AML cells through paracrine cytokine secretion of hepatocyte growth factor (HGF) and CSF1 and that utilizing CSF1R inhibitors may be an effective treatment in a subpopulation of AML patients (94, 101). This evidence concerns the gene CSF1R and acute myeloid leukemia.